Saving Lives of Cancer Patients by Addressing Cancer-Associated Thrombosis

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...
Header image

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 24 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

ETHA has come together to give the European thrombosis and hemostasis community an allied voice and to provide input to EU health and patient safety strategies, make recommendations on EU research programme funding and encourage sharing and adoption of best practices in the treatment and prevention of thrombotic and bleeding disorders.

To learn more about ETHA’s initial areas of priority, read its consensus statement, here.

News

Europe’s Beating Cancer Plan – Consultation Responses Su...

On 3 March, the European Thrombosis and Haemostasis Alliance (ETHA) submitted its consultation response on Europe’s Beating Cancer Plan to the European Commission and joined with the Cancer Related Complications and Comorbidit...

Continue reading

ETHA Signs a Joint Statement on Cancer Comorbidities

On 17 December 2019, the European Thrombosis and Haemostasis Alliance (ETHA) signed a joint statement as part of a new coalition on cancer comorbidities. Alongside ten signatories including the European Cancer Patient Coalition (ECP...

Continue reading